Form 4: Argan Director Sells $4.2M in Stock

Argan Inc. Director William F. Leimkuhler sold 11,044 shares of common stock for approximately $4.2 million in a pre-planned transaction.

Summary

• William F. Leimkuhler, a Director of Argan Inc. (AGX), sold 11,044 shares of the company's common stock.
• The transaction occurred on January 16, 2026, at an average price of $379.15 per share.
• The total value of the shares sold is approximately $4,187,000.60.
• Following this sale, Leimkuhler directly beneficially owns 49,939 shares of Argan Inc. common stock.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-scheduled sale.

Sentiment

Score: 4

Explanation: While the sale is pre-planned under a 10b5-1 plan, which mitigates immediate negative sentiment, a significant insider sale by a Director can still be interpreted by some investors as a lack of conviction or a move to diversify, potentially creating a slight negative overhang. The large dollar value of the sale also contributes to this perception.

Negatives

• A Director selling a significant number of shares (11,044 shares) could be perceived negatively by the market, potentially signaling a lack of confidence, even if pre-planned.
• The sale represents a reduction in the Director's direct beneficial ownership from 60,983 shares (49,939 + 11,044) to 49,939 shares.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May view the sale as a signal, potentially impacting investor confidence or stock price, despite the 10b5-1 plan.

Key Dates

Recommendation

The sale by Director William F. Leimkuhler, while substantial at over $4.1 million, was executed under a Rule 10b5-1 plan. This indicates a pre-scheduled transaction rather than a reaction to new, undisclosed information, which typically lessens the negative signal of insider selling. However, any significant insider sale can still create a perception of reduced confidence or a desire for diversification. Given the pre-planned nature, it doesn't warrant an immediate 'sell' recommendation, but it also doesn't provide a 'buy' signal. A 'hold' recommendation is appropriate as investors should monitor future filings and company performance for more definitive signals.

Keywords

Argan Inc., AGX, Insider Sale, Form 4, Director Stock Sale, William F. Leimkuhler, Equity Transaction, Rule 10b5-1